Dual effects of Psoraleae Fructus on the liver: hepatoprotection or hepatoxicity?

Abstract

Psoraleae Fructus, the dried mature fruit of the leguminous plant Psoralea corylifolia L., contains flavonoids, coumarins, monoterpene phenols, and benzofurans. It exhibits various pharmacological activities, including immune regulation, antioxidant properties, photosensitivity, and estrogen-like effects, and finds extensive use in the clinical treatment of osteoporosis, vitiligo, and psoriasis. Extensive pharmacological research has demonstrated that Psoraleae Fructus and its components improve liver function and protect hepatocytes in animal and cellular models of liver diseases. Moreover, with the increasing clinical applications of Psoraleae Fructus and its derivatives, as well as the progression in adverse drug reaction surveillance, there is an increase in clinical cases involving these preparations and the enhancement of monitoring for any adverse reactions linked to Psoraleae Fructus and its related compounds. Here, we examined the hepatoprotective effects and hepatotoxicity of the monomer components, extracts, and related preparations of Psoraleae Fructus. We aim to contribute to safety evaluation, facilitate informed clinical application, and foster advancements in Psoraleae Fructus and its derivatives.

Keywords

DILI / Hepatic protection / Hepatotoxicity / Psoralea corylifolia L / Psoraleae Fructus

References

[[1]] Zhang XN, Zhao WW, Wang Y, et al. The chemical constituents and bioactivities of Psoralea corylifolia Linn.: a review. Am J Chin Med. 2016;44(1):35-60.

[[2]] Chen L, Chen S, Sun P, et al. Psoralea corylifolia L.: a comprehensive review of its botany, traditional uses, phytochemistry, pharmacology, toxicology, quality control and pharmacokinetics. Chin Med. 2023;18(1):4.

[[3]] Im AR, Chae SW, Zhang GJ, et al. Neuroprotective effects of Psoralea corylifolia Linn seed extracts on mitochondrial dysfunction induced by 3-nitropropionic acid. BMC Complement Altern Med. 2014;14:370.

[[4]] Jing H, Wang S, Wang M, et al. Isobavachalcone attenuates MPTP-induced Parkinson’s disease in mice by inhibition of microglial activation through NF-κB pathway. PLoS One. 2017;12(1):e0169560.

[[5]] Chowdhury AA, Gawali NB, Shinde P, et al. Imperatorin ameliorates lipopolysaccharide induced memory deficit by mitigating proinflammatory cytokines, oxidative stress and modulating brain-derived neurotropic factor. Cytokine. 2018;110:78-86.

[[6]] Feng JY, Yang Y, Zhou YJ, et al. Bakuchiol attenuates myocardial ischemia reperfusion injury by maintaining mitochondrial function: the role of silent information regulator 1. Apoptosis. 2016;21(5):532-545.

[[7]] Zhang XX, Chang N, Zhang Y, et al. Bakuchiol protects against acute lung injury in septic mice. Inflammation. 2017;40(2):351-359.

[[8]] Tominaga M, Tengara S, Kamo A, et al. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci. 2009;55(1):40-46.

[[9]] Xin ZL, Wu X, Ji T, et al. Bakuchiol: a newly discovered warrior against organ damage. Pharmacol Res. 2019;141:208-213.

[[10]] Zhang Y, Lu Q, Liu SS, et al. Psoralen ameliorates acetaminophen-induced acute liver injury by inhibiting the enzymatic activity of CYP2E1. Rev Bras Farmacognosia. 2023;33(5):1060-1071.

[[11]] Alam F, Khan GN, Asad M. Psoralea corylifolia L: ethnobotanical, biological, and chemical aspects: a review. Phytother Res. 2018;32(4):597-615.

[[12]] Shi Z, Gao J, Pan J, et al. A systematic review on the safety of Psoraleae Fructus: potential risks, toxic characteristics, underlying mechanisms and detoxification methods. Chin J Nat Med. 2022;20(11):805-813.

[[13]] Ren YL, Song XMT, Tan L, et al. A review of the pharmacological properties of psoralen. Front Pharmacol. 2020;11:571535.

[[14]] He JB, Li XJ, Wang ZY, et al. Therapeutic anabolic and anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis. Front Pharmacol. 2019;10:1344.

[[15]] Yu YL, Wang PL, Yu RL, et al. Long-term exposure of psoralen and isopsoralen induced hepatotoxicity and serum metabolites profiles changes in female rats. Metabolites. 2019;9(11):263.

[[16]] Wang X, Lou YJ, Wang MX, et al. Furocoumarins affect hepatic cytochrome P450 and renal organic ion transporters in mice. Toxicol Lett. 2012;209(1):67-77.

[[17]] Wang Y, Zhang H, Jiang JM, et al. Multiorgan toxicity induced by EtOH extract of Fructus Psoraleae in Wistar rats. Phytomedicine. 2019;58:152874.

[[18]] Diawara MM, Kulkosky PJ. Reproductive toxicity of the psoralens. Pediatr Pathol Mol Med. 2003;22(3):247-258.

[[19]] Hinton AN, Goldminz AM. Feeling the burn: phototoxicity and photoallergy. Dermatol Clin. 2020;38(1):165-175.

[[20]] Piao SJ, Lin HW, Tao X, et al. Mitochondrial toxicants in Xian-Ling-Gu-Bao induce liver injury by regulating the PI3K/mTOR signaling pathway: an in vitro study. BMC Complement Med Ther. 2022;22(1):317.

[[21]] Lee WM.Acetaminophen (APAP) hepatotoxicity-Isn’t it time for APAP to go away? J Hepatol. 2017;67(6):1324-1331.

[[22]] Hoofnagle JH, Björnsson ES. Drug-induced liver injury—types and phenotypes. N Engl J Med. 2019;381(3):264-273.

[[23]] Yan M, Huo Y, Yin S, et al. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol. 2018;17:274-283.

[[24]] Jaeschke H, Ramachandran A. Acetaminophen hepatotoxicity: paradigm for understanding mechanisms of drug-induced liver injury. Annu Rev Pathol. 2024;19:453-478.

[[25]] Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Arch Toxicol. 2015;89(2):193-199.

[[26]] Alehaideb Z, Sheriffdeen M, Law FCP. Inhibition of caffeine metabolism by apiaceous and rutaceae families of plant products in humans: in vivo and in vitro studies. Front Pharmacol. 2021;12:641090.

[[27]] Kang AY, Young LR, Dingfelder C, et al. Effects of furanocoumarins from apiaceous vegetables on the catalytic activity of recombinant human cytochrome P-450 1A2. Protein J. 2011;30(7):447-456.

[[28]] Alehaideb Z, Matou-Nasri S. Determination of benchmark doses for linear furanocoumarin consumption associated with inhibition of cytochrome P450 1A2 isoenzyme activity in healthy human adults. Toxicol Rep. 2021;8:1437-1444.

[[29]] Lo WS, Lim YP, Chen CC, et al. A dual function of the furanocoumarin chalepensin in inhibiting Cyp2a and inducing Cyp2b in mice: the protein stabilization and receptor-mediated activation. Arch Toxicol. 2012;86(12):1927-1938.

[[30]] Liu SS, Cheng RH, He H, et al. 8-methoxypsoralen protects against acetaminophen-induced liver injury by antagonising Cyp2e1 in mice. Arch Biochem Biophys. 2023;741:109617.

[[31]] Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet (London, England). 2021;397(10290):2212-2224.

[[32]] Paternostro R, Trauner M. Current treatment of non-alcoholic fatty liver disease. J Intern Med. 2022;292(2):190-204.

[[33]] Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22(7):429-443.

[[34]] Seo E, Oh YS, Jun HS. Psoralea corylifolia L. Seed extract attenuates nonalcoholic fatty liver disease in high-fat diet-induced obese mice. Nutrients. 2016;8(2):83.

[[35]] Zhou LS, Tang JQ, Xiong XL, et al. Psoralea corylifolia L. Attenuates nonalcoholic steatohepatitis in juvenile mouse. Front Pharmacol. 2017;8:876.

[[36]] Chen Z, Tian RF, She ZG, et al. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116-141.

[[37]] Lee KC, Wu PS, Lin HC. Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis. Clin Mol Hepatol. 2023;29(1):77-98.

[[38]] Zhou L, Tang J, Yang X, et al. Five Constituents in Psoralea corylifolia L. Attenuate palmitic acid-induced hepatocyte injury via inhibiting the protein kinase C-α/nicotinamide-adenine dinucleotide phosphate oxidase pathway. Front Pharmacol. 2019;10:1589.

[[39]] Barchetta I, Cimini FA, Cavallo MG. Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): an update. Nutrients. 2020;12(11):3302.

[[40]] Jaroenlapnopparat A, Suppakitjanusant P, Ponvilawan B, et al. Vitamin D-related genetic variations and nonalcoholic fatty liver disease: a systematic review. Int J Mol Sci. 2022;23(16):9122.

[[41]] Liu JQ, Song Y, Wang Y, et al. Vitamin D/vitamin D receptor pathway in non-alcoholic fatty liver disease. Expert Opin Ther Targets. 2023;27(11):1145-1157.

[[42]] Zhao GL, Elhafiz M, Jiang JW, et al. Adaptive homeostasis of the vitamin D-vitamin D nuclear receptor axis in 8-methoxypsoralen-induced hepatotoxicity. Toxicol Appl Pharmacol. 2019;362:150-158.

[[43]] Elhafiz M, Zhao GL, Ismail M, et al. Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(6):158657.

[[44]] Wei X, Lin L, Yuan QQ, et al. Bavachin protects against diet-induced hepatic steatosis and obesity in mice. Acta Pharmacol Sin. 2023;44(7):1416-1428.

[[45]] Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589-604.

[[46]] Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma. Lancet (London, England). 2022;400(10360):1345-1362.

[[47]] Brown ZJ, Tsilimigras DI, Ruff SM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158(4):410-420.

[[48]] Bae K, Park JH, Kim J, et al. Traditional oriental herbal medicine and natural killer cells for cancer patients: a systematic review and meta-analysis. Phytother Res. 2017;31(4):519-532.

[[49]] Tariq A, Sadia S, Pan K, et al. A systematic review on ethnomedicines of anti-cancer plants. Phytother Res. 2017;31(2):202-264.

[[50]] Xiong J, Yang H, Luo W, et al. The anti-metastatic effect of 8-MOP on hepatocellular carcinoma is potentiated by the down-regulation of bHLH transcription factor DEC1. Pharmacol Res. 2016;105:121-133.

[[51]] Jiang ZY, Xiong J. Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by psoralen from Psoralea corylifolia. Cell Biochem Biophys. 2014;70(2):1075-1081.

[[52]] Wang XM, Peng PK, Pan ZQ, et al. Psoralen inhibits malignant proliferation and induces apoptosis through triggering endoplasmic reticulum stress in human SMMC7721 hepatoma cells. Biol Res. 2019;52(1):34.

[[53]] Rebouissou S, Zucman-Rossi J, Moreau R, et al. Note of caution: contaminations of hepatocellular cell lines. J Hepatol. 2017;67(5):896-897.

[[54]] Bian XC, Yang ZL, Feng HL, et al. A combination of species identification and STR profiling identifies cross-contaminated cells from 482 human tumor cell lines. Sci Rep. 2017;7(1):9774.

[[55]] Huang YQ, Liu YH, Zheng CY, et al. Investigation of cross-contamination and misidentification of 278 widely used tumor cell lines. PLoS One. 2017;12(1):e0170384.

[[56]] Murphy MP, Hartley RC. Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discovery. 2018;17(12):865-886.

[[57]] Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155(3):629-647.

[[58]] Mihajlovic M, Vinken M. Mitochondria as the target of hepatotoxicity and drug-induced liver injury: molecular mechanisms and detection methods. Int J Mol Sci. 2022;23(6):3315.

[[59]] Guo ZJ, Li P, Wang CG, et al. Five constituents contributed to the Psoraleae Fructus-induced hepatotoxicity via mitochondrial dysfunction and apoptosis. Front Pharmacol. 2021;12:682823.

[[60]] Yang Y, Tang X, Hao F, et al. Bavachin induces apoptosis through mitochondrial regulated ER stress pathway in HepG2 cells. Biol Pharm Bull. 2018;41(2):198-207.

[[61]] Yang Y, Zhou W, Wang Y, et al. Bavachin induces liver injury and cell apoptosis by targeting Wnt/β-catenin/DRP1 signaling pathway mediated mitochondrial dysfunction. Toxicol Lett. 2023;387:1-13.

[[62]] Marciniak SJ, Chambers JE, Ron D. Pharmacological targeting of endoplasmic reticulum stress in disease. Nat Rev Drug Discovery. 2022;21(2):115-140.

[[63]] Chen X, Shi C, He M, et al. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):352.

[[64]] Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21(8):421-438.

[[65]] Zhang J, Guo J, Yang N, et al. Endoplasmic reticulum stress-mediated cell death in liver injury. Cell Death Dis. 2022;13(12):1051.

[[66]] Ajoolabady A, Kaplowitz N, Lebeaupin C, et al. Endoplasmic reticulum stress in liver diseases. Hepatology. 2023;77(2):619-639.

[[67]] Yu Y, Yu R, Men W, et al. Psoralen induces hepatic toxicity through PERK and ATF6 related ER stress pathways in HepG2 cells. Toxicol Mech Methods. 2020;30(1):39-47.

[[68]] Yang Y, Guo GM, Zhou W, et al. Sestrin2 protects against bavachin induced ER stress through AMPK/mTORC1 signaling pathway in HepG2 cells. J Pharmacol Sci. 2021;145(2):175-186.

[[69]] Allison R, Guraka A, Shawa IT, et al. Drug induced liver injury—a 2023 update. J Toxicol Environ Health Part B. 2023;26(8):442-467.

[[70]] Gijbels E, Vilas-Boas V, Deferm N, et al. Mechanisms and in vitro models of drug-induced cholestasis. Arch Toxicol. 2019;93(5):1169-1186.

[[71]] Andrade RJ, Chalasani N, Björnsson ES, et al. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5(1):58.

[[72]] Deferm N, De Vocht T, Qi B, et al. Current insights in the complexities underlying drug-induced cholestasis. Crit Rev Toxicol. 2019;49(6):520-548.

[[73]] Sundaram V, Björnsson ES. Drug-induced cholestasis. Hepatol Commun. 2017;1(8):726-735.

[[74]] Wang JY, Jiang ZZ, Ji JZ, et al. Evaluation of hepatotoxicity and cholestasis in rats treated with EtOH extract of Fructus Psoraleae. J Ethnopharmacol. 2012;144(1):73-81.

[[75]] Li ZJ, Abudumijiti A, Xu DQ, et al. Quantitative proteomics analysis of Fructus Psoraleae-induced hepatotoxicity in rats. Chin J Nat Med. 2020;18(2):123-137.

[[76]] Zhao GL, Xu DQ, Yuan ZQ, et al. 8-Methoxypsoralen disrupts MDR3-mediated phospholipids efflux and bile acid homeostasis and its relevance to hepatotoxicity. Toxicology. 2017;386:40-48.

[[77]] Chen MY, Wang Q, Meng ZJ, et al. Psoralen induces liver injury and affects hepatic bile acids metabolism in female and male C57BL/6J mice. Phytother Res. 2023;37(6):2280-2289.

[[78]] Li ZJ, Abulizi A, Zhao GL, et al. Bakuchiol contributes to the hepatotoxicity of Psoralea corylifolia in rats. Phytother Res. 2017;31(8):1265-1272.

[[79]] Gao SY, Xu DQ, Abulizi A, et al. iTRAQ quantitative proteomic analysis of different expressed proteins and signal pathways in bakuchiol-induced hepatotoxicity. Evid Based Complement Alternat Med. 2022;2022:2928240.

[[80]] Sernoskie SC, Jee A, Uetrecht JP. The emerging role of the innate immune response in idiosyncratic drug reactions. Pharmacol Rev. 2021;73(3):861-896.

[[81]] Jee A, Sernoskie SC, Uetrecht J. Idiosyncratic drug-induced liver injury: mechanistic and clinical challenges. Int J Mol Sci. 2021;22(6):2954.

[[82]] Li C, Rao T, Chen X, et al. HLA-B*35:01 allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans. Hepatology. 2019;70(1):346-357.

[[83]] Rao T, Liu YT, Zeng XC, et al. The hepatotoxicity of Polygonum multiflorum: the emerging role of the immune-mediated liver injury. Acta Pharmacol Sin. 2021;42(1):27-35.

[[84]] Frenzel C, Teschke R. Herbal hepatotoxicity: clinical characteristics and listing compilation. Int J Mol Sci. 2016;17(5):588.

[[85]] Gao Y, Wang Z, Tang J, et al. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions. Front Med. 2020;14(1):68-80.

[[86]] Li CY, Niu M, Liu YL, et al. Screening for susceptibility-related factors and biomarkers of Xianling Gubao capsule-induced liver injury. Front Pharmacol. 2020;11:810.

[[87]] Qin N, Xu G, Wang Y, et al. Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicity. Front Med. 2021;15(4):594-607.

[[88]] Wang Y, Xu G, Wang Z, et al. Psoralidin, a major component of Psoraleae Fructus, induces inflammasome activation and idiosyncratic liver injury. Int Immunopharmacol. 2021;92:107352.

RIGHTS & PERMISSIONS

2024 Acupuncture and Herbal Medicine